Literature DB >> 21393102

TREM-1 interaction with the LPS/TLR4 receptor complex.

Rob J W Arts1, Leo A B Joosten, Charles A Dinarello, Bart Jan Kullberg, Jos W M van der Meer, Mihai G Netea.   

Abstract

Triggering receptor expressed on myeloid cells 1 (TREM-1) is an activating receptor expressed on neutrophils and monocytes that amplifies inflammation induced by stimulation of pattern-recognition receptors. In this study, several lines of evidence are presented that TREM-1 interacts with the toll-like receptor 4 (TLR4) receptor complex, or is a component of this complex. Blocking anti-TREM-1 antibodies specifically inhibited LPS-induced TNF-α production, while the alternative approach of blocking TLR4 by a specific inhibitor led to a down-regulation of the effects of TREM-1 cross-linking. These data are in line with the TLR4-TREM1 co-localization in human neutrophils and suggests that, at least some of the biological effects of TREM-1 may be due to its interaction with the TLR4/LPS-receptor complex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393102     DOI: 10.1684/ecn.2011.0274

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  25 in total

Review 1.  Triggering receptor expressed on myeloid cells receptor family modulators: a patent review.

Authors:  Christopher J Pelham; Amit N Pandya; Devendra K Agrawal
Journal:  Expert Opin Ther Pat       Date:  2014-11-01       Impact factor: 6.674

2.  Gene Expression Profiling in Blood Provides Reproducible Molecular Insights into Asthma Control.

Authors:  Damien C Croteau-Chonka; Weiliang Qiu; Fernando D Martinez; Robert C Strunk; Robert F Lemanske; Andrew H Liu; Frank D Gilliland; Joshua Millstein; W James Gauderman; Carole Ober; Jerry A Krishnan; Steven R White; Edward T Naureckas; Dan L Nicolae; Kathleen C Barnes; Stephanie J London; Albino Barraza-Villarreal; Vincent J Carey; Scott T Weiss; Benjamin A Raby
Journal:  Am J Respir Crit Care Med       Date:  2017-01-15       Impact factor: 21.405

3.  [Expression of triggering receptors expressed by myeloid cells-1 in macrophages stimulated by Porphyromonas gingivalis-lipopolysaccharide].

Authors:  Yun Yang; Shan-Shan Chen; Chun-Mei Xu; Ya-Fei Wu; Lei Zhao
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-10-01

4.  The cytotoxic type 3 secretion system 1 of Vibrio rewires host gene expression to subvert cell death and activate cell survival pathways.

Authors:  Nicole J De Nisco; Mohammed Kanchwala; Peng Li; Jessie Fernandez; Chao Xing; Kim Orth
Journal:  Sci Signal       Date:  2017-05-16       Impact factor: 8.192

5.  Activation of the TREM-1 pathway in human monocytes by periodontal pathogens and oral commensal bacteria.

Authors:  M Varanat; E M Haase; J G Kay; F A Scannapieco
Journal:  Mol Oral Microbiol       Date:  2016-09-06       Impact factor: 3.563

6.  Toll-like receptor 4-linked Janus kinase 2 signaling contributes to internalization of Brucella abortus by macrophages.

Authors:  Jin Ju Lee; Dong Hyeok Kim; Dae Geun Kim; Hu Jang Lee; Wongi Min; Man Hee Rhee; Jae Youl Cho; Masahisa Watarai; Suk Kim
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

Review 7.  Novel ligands and modulators of triggering receptor expressed on myeloid cells receptor family: 2015-2020 updates.

Authors:  Harbinder Singh; Vikrant Rai; Sunil K Nooti; Devendra K Agrawal
Journal:  Expert Opin Ther Pat       Date:  2021-02-08       Impact factor: 6.714

8.  Extracellular CIRP and TREM-1 axis promotes ICAM-1-Rho-mediated NETosis in sepsis.

Authors:  Atsushi Murao; Adnan Arif; Max Brenner; Naomi-Liza Denning; Hui Jin; Satoshi Takizawa; Benjamin Nicastro; Ping Wang; Monowar Aziz
Journal:  FASEB J       Date:  2020-06-07       Impact factor: 5.834

9.  Reduced Uterine Tissue Damage during Chlamydia muridarum Infection in TREM-1,3-Deficient Mice.

Authors:  Bryan E McQueen; Avinash Kollipara; Clare E Gyorke; Charles W Andrews; Ashley Ezzell; Toni Darville; Uma M Nagarajan
Journal:  Infect Immun       Date:  2021-06-14       Impact factor: 3.441

10.  Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension.

Authors:  Nicholas W Morrell; Stephen L Archer; Albert Defelice; Steven Evans; Monica Fiszman; Thomas Martin; Muriel Saulnier; Marlene Rabinovitch; Ralph Schermuly; Duncan Stewart; Hubert Truebel; Gennyne Walker; Kurt R Stenmark
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.